Immunogenicity of HPV Vaccine in Immunosuppressed Children
Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV Vaccine
Sponsor: Sydney Children's Hospitals Network
Listed as NCT02263703, this PHASE3 trial focuses on Autoimmune Disease and Bone Marrow Transplant Infection and remains completed. Sponsored by Sydney Children's Hospitals Network, it has been updated 8 times since 2007, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jun 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jun 2017 — Oct 2017 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
May 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sydney Children's Hospitals Network
- The University of New South Wales
- Women's and Children's Hospital, Australia
For direct contact, visit the study record on ClinicalTrials.gov .